Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy)”

2 trials

Showing 2 of 2 results

Testing effectiveness (Phase 2)Study completedNCT01108055
What this trial is testing

Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer

Who this might be right for
Bladder CancerBladder (Urothelial, Transitional Cell) CancerBladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)+2 more
Sandy Srinivas 43
Not applicableWithdrawnNCT01060319
What this trial is testing

A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies

Who this might be right for
Bladder CancerSkin CancersBladder (Urothelial, Transitional Cell) Cancer+1 more
Stanford University

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation